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Careful interpretation of liver function tests within the clinical context can help elucidate the cause and severity of the 
underlying pathology. Predominantly raised alkaline phosphatase represents the cholestatic pattern of biliary pathology, 
whilst predominantly raised alanine aminotransferase and aspartate aminotransferase represent the hepatocellular pattern 
of hepatocellular pathology. The severity of liver dysfunction or biliary obstruction is reflected in the bilirubin level and the 
degree of liver synthetic function can also be indicated by the albumin level. Beyond the liver function tests, prothrombin 
time provides another marker of liver synthetic function and a low platelet count suggests portal hypertension.
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Introduction
Derangement of liver function tests (LFTs) is a 
common problem that can be difficult to interpret. The 
clinical context is an important guide, but liver disease can 
be asymptomatic until the late stages and abnormal blood 
tests may be the first indication of disease. This review 
will guide you through the individual  LFT’s and how to 
interpret them. 
What are the LFTs?
LFTs include liver enzymes, albumin and other 
proteins, and bilirubin. The liver enzymes are produced 
by cells within the liver. They include alkaline phosphatase 
(ALP), γ–glutamyl transpedtidase (GGT), alanine 
aminotransferase (ALT) and aspartate aminotransferase 
(AST), but the combination of liver enzyme results you 
receive depends on your local laboratory. The protein 
components comprise total protein, albumin and 
globulin [N.B. Total protein = Albumin + Globulins]. 
The globulins are a mixture of globular proteins such 
as immunoglobulins, enzymes, carrier proteins and 
complement. 
The LFT’s reflect a limited range of hepatic metabolic 
processes. Bilirubin is an indication of the detoxification/
excretory function and albumin reflects the synthetic 
function.
Typical normal ranges for LFTs and other blood tests 
are shown in Table 1, but may vary according to your 
local laboratory. 
Liver enzymes
The liver enzymes are in two main groups – ALP and 
GGT, produced predominantly by the bile ducts; and 
ALT and AST, produced predominantly by hepatocytes. 
Liver enzymes are a poor reflector of liver function, but 
rather of cholestasis and liver cell integrity, respectively [1]. 
Liver enzymes have different normal ranges, so 
assessment of their relative abnormalities by number of 
times greater than their upper limit of normal (ULN) can 
be more informative than the absolute values. 
When ALP is raised more times its ULN than either 
ALT or AST, this suggests a cholestatic pattern indicating 
biliary pathology. In the acute setting, a cholestatic pattern 
of LFTs is seen with bile stones, when accompanied 
by colicky right upper quadrant pain or in cholestatic 
drug-induced liver injury when there is a history of a 
new causative medication. A more chronic presentation 
may be due to pancreatic, liver or bile duct tumours or 
cholestatic autoimmune liver disease such as primary 
biliary cholangitis or primary sclerosing cholangitis. 
ALP is also produced outside the liver by organs such 
as bone, placenta, kidneys and gut.  Hence ALP may 
be raised in the presence of normal liver health, most 
commonly due to bone disease or pregnancy. A raised 
GGT and/or other abnormalities in the LFTs would 
indicate a liver source of raised ALP. The ALP isoenzyme 
can also help differentiate a liver versus bone origin. If all 
other liver tests are normal, raised calcium or phosphorus 
levels may also indicate a bone source.
GGT is induced by alcohol and other drugs and so 
lacks specificity for many liver diseases, except in the 
context of ALP. 
ALT and AST are produced mostly by hepatocytes. 
However, ALT occurs at low concentrations in skeletal 
muscle and kidney, and AST is found in kidney, heart, 
brain, red blood cells and skeletal muscle [1]. Abnormalities 
in ALT and AST are fairly specific to the liver however.
When ALT or AST are raised more times their ULN 
than ALP, this is described as a hepatocellular pattern. 
This state reflects disease processes affecting hepatocytes 
such as viral hepatitis, metabolic liver diseases, drug or 
alcohol toxicity and autoimmune hepatitis. Abnormalities 
in these liver enzymes are generally considered mild if 
<5 times the ULN, moderate if 5-10 times the ULN or 
marked if >10 times the ULN. 
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In alcoholic hepatitis, an ALT over 300 IU/l is rare, but 
increased AST/ALT ratio is often observed. In contrast, 
the AST/ALT ratio is low in non-alcoholic steatohepatitis 
[2], often accompanied by a modestly elevated GGT. 
Although there are many differential diagnoses for mild 
to modest elevations in ALT or AST, marked elevations 
are usually only caused by acute drug-induced liver 
injury, viral hepatitis or ischaemic liver injury. Detailed 
history for drug and toxin exposure, viral hepatitis risk 
factors and inter-current illness resulting in hypotension 
should be taken. The patient should also be monitored for 
fulminant liver failure. 
In reality, the pattern of LFTs may not be clear-cut 
and an apparently hepatocellular pattern can reflect an 
acute cholestatic cause such as biliary stones. Typically, 
the raised ALT or AST in this situation resolves quickly 
once the obstruction is relieved. Clinical context and 
further assessments are therefore needed to help make the 
diagnosis. 
The timing of liver enzyme abnormalities may 
differentiate acute from chronic liver disease, but note 
that in the chronic setting, significant liver damage such as 
cirrhosis can exist with normal liver enzyme levels. Raised 
liver enzymes are not a reliable screening test for cirrhosis.
Bilirubin
Bilirubin is the product of haemoglobin breakdown. 
Lipid-soluble, unconjugated bilirubin is conjugated in the 
liver, making it water-soluble, and then excreted into bile. 
When a raised bilirubin or clinical jaundice is found we 
should consider haemolysis (production of unconjugated 
bilirubin), liver cell function (conjugation and excretion 
of bilirubin) and biliary tree function (excretion of bile). 
A raised bilirubin level is a strong indicator of underlying 
pathology and should always be investigated with a careful 
clinical history and appropriate investigations. A liver 
ultrasound is usually necessary.
In haemolysis, red cell rupture releases free 
haemoglobin, raising blood levels of unconjugated 
bilirubin. The diagnosis of haemolysis may be supported 
by reduced haemoglobin, reduced haptoglobins, increased 
reticulocyte count and an abnormal blood film, whilst 
other LFTs and liver ultrasound are normal. 
Unconjugated bilirubin is also raised in Gilbert’s 
syndrome, a benign, inherited disease. Patients are well 
in Gilbert’s syndrome, but their bilirubin levels may rise 
particularly during inter-current illnesses, whilst other 
liver tests and liver ultrasound remain normal. Gilbert’s 
syndrome can be diagnosed clinically. 
In liver cell or biliary pathology with a raised bilirubin, 
a hepatocellular or cholestatic liver enzyme pattern is 
often present and possible abnormalities in liver synthetic 
function. Consideration of these other LFTs, the 
clinical history and a liver ultrasound to look for biliary 
obstruction, liver lesions or liver parenchymal change are 
useful.
Unlike the liver enzymes, the bilirubin can be a useful 
marker of liver function, as bilirubin rises with increasing 
severity of liver disease. Bilirubin has been incorporated 
into a number of composite scores, which assess liver 
disease severity including the Child Pugh [3] and model 
for end-stage liver disease (MELD) scores [4].
Albumin
Albumin is a protein synthesized exclusively in the 
liver. As such it is a marker of liver synthetic function and 
liver health. The half-life of albumin is 20 days and so a 
low albumin may be seen in chronic or sub-acute liver 
disease, but may not be observed in acute liver injury [1]. 
Albumin levels can be reduced by many kinds of illnesses 
and so has relatively low specificity as a marker of liver 
function. None-the-less a low albumin has prognostic 
significance and forms part of the Child Pugh score.
Other assessments of the liver function
The LFTs are not the only blood tests indicating liver 
function. In particular the prothrombin time (PT) or 
international normalised ratio (INR), and platelet count 
contribute to a more comprehensive assessment. 
The PT is governed by the activity of clotting factors, 
Component Abbreviation Normal range
Bilirubin Bili <21 µmol/l
Alkaline phosphatase ALP 30-130 IU/l
γ –glutamyl transpedtidase GGT 11-55 IU/l




Albumin Alb 35-50 g/l
Globulin Glob 20-40 g/l
Total protein TP 60-80 g/l
Haemoglobin Hb 135-185 g/l
Mean cell volume MCV 78-100 fl












C-reactive protein CRP <5 mg/l
Table 1. Normal values for blood tests
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which are produced by the liver and have a half-life of 
about one day [1]. The production of these clotting 
factors is dependent on adequate vitamin K and so clotting 
may also be prolonged by vitamin K deficiency. In the 
absence of vitamin K deficiency or anticoagulants (e.g. 
warfarin), PT is a good marker of liver function in both 
acute and chronic settings. The international normalized 
ratio (INR) also reflects clotting and liver synthetic 
function in the same way and unlike PT, is standardised 
across laboratories. Liver function must be quite severely 
impaired to affect PT or INR and so mild liver disease or 
a state of compensated cirrhosis will likely have normal 
values. The PT and INR form part of the Child Pugh and 
MELD scores, respectively.
Importantly, the liver makes both clotting and 
fibrinolytic products and so it should not be assumed that 
a raised PT indicates a hypocoagulable state in the context 
of liver disease. 
Cirrhosis can cause increased pressure in the portal 
vein that carries blood from the gut and the spleen to 
the liver. This is called portal hypertension. When this 
develops, the spleen becomes engorged with blood and 
consumes platelets. A low platelet count is a marker of 
portal hypertension [5] and may be the first indicator of 
chronic liver disease. Portal hypertension causes many of 
the complications of chronic liver disease such as variceal 
bleeds, ascites and hepatic encephalopathy and so the 
finding of a low platelet count in this context is a poor 
prognostic sign.
The underlying etiology
Despite meticulous interpretation of the LFTs, the 
underlying cause of liver disease may still not be apparent. 
When presented with a patient with liver test abnormalities 
or a clinical suspicion of chronic liver disease, it is often 
necessary to perform a liver screen. Detailed discussion of 
the liver screen is beyond the context of this article, but is 
summarised in Table 2. The liver screen does not contain 
specific tests for alcohol-related liver disease, non-alcoholic 
fatty liver disease (NAFLD) or drug-induced liver injury 
amongst others, so careful history and assessment of liver 
disease risk factors are still vital. 
In the acute setting, hepatitis A, hepatitis E, Epstein-
Barr virus, cytomegalovirus, human immunodeficiency 
virus and stool examination for schistosomiasis ova may 
also be considered.
Simple non-invasive scores of liver fibrosis
Although the simple presence of raised liver enzyme 
levels is not a reliable way of diagnosing cirrhosis, liver 
function blood tests can be used in combination to 
predict the presence of liver fibrosis. Detailed description 
and discussion of these scores is beyond the scope of this 
article, but commonly used scores include the AST/ALT 
ratio [6], AST to platelet ratio index (APRI) [7], fibrosis 
4 (FIB-4) [8] and NAFLD fibrosis risk score [9]. The 
World Health Organisation recommends the use of APRI 
or FIB-4 scores for the assessment of chronic hepatitis C 
related liver fibrosis to aid decision-making on hepatitis C 
treatment allocation [10]. 
Summary
Deranged LFTs are a common problem and their 
interpretation is complicated by the production of liver 
enzymes from multiple organs and the lack of specificity 
for markers of liver function.  Therefore it is important to 
interpret liver tests within the clinical context. Raised ALP 
reflects biliary tree injury and cholestasis, whereas raised 
AST and ALT levels usually reflect hepatocyte injury. 
Raised bilirubin and low albumin are the LFT components 
that can reflect impaired liver function, whilst raised PT 
or INR also provide a marker of liver synthetic function. 
A low platelet count may be seen in cirrhosis and signify 
the onset of portal hypertension.
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Quiz on Liver Function Tests (see the article on page 40) 
Test your knowledge and find 
the best matches between the 
following statements and the blood 
test results in the table. See page 47 
for the answers. 
1. A 30-year old female presents 
to clinic with fevers, vomiting, 
lethargy and myalgia for 1 week. 
There is a mild continuous right 
upper quadrant ache. She takes no 
medications or alcohol. Two of her 
family members have also been 
similarly unwell.
2. A 51-year old male presents with 
tense abdominal distension. He 
drinks 80 units of alcohol per week. 
3. A 76-year old male with known 
prostate cancer presents with back 
pain.
4. A 16-year old male presents with 
lethargy and breathlessness. 
5. A 41-year old female with biopsy-
proven HCV cirrhosis who had 
successful HCV treatment 2 years 
ago. 
6. A 40-year old female presents 
with 2 days of colicky right upper 
quadrant pain and nausea.
Table 1. Age and parity of 100 patients
A B C D E F
Bilirubin (µmol/l) 12 45 63 34 41 15
Alkaline phosphatase 
(IU/l)
199 338 371 173 49 56
γ–glutamyl 
transpedtidase (IU/l)








21 63 1883 89 17 34
Albumin (g/l) 35 41 37 22 40 38
Globulin (g/l) 24 20 27 23 29 20
Total protein (g/l) 59 61 64 45 69 58
Haemoglobin (g/l) 136 149 138 115 81 141
Mean cell volume (fl) 98 97 94 108 105 95
White cell count 
(x109/l)
5.1 8.0 10.0 4.3 5.0 3.9
Platelets (x109/l) 299 307 400 86 249 237
Prothrombin time (s) 11 10 12 15 11 10
International 
normalized ratio
1.0 1.0 1.1 1.4 1.0 0.9
Urea (mg/dl) 6.5 5.9 6.4 2.0 3.5 3.8
Creatinine (µmol/l) 127 109 97 49 67 57
C-reactive protein 
(mg/l)
5 9 30 2 3 1
